Medtronic, Inc. (MDT) Reports Q4 EPS of 90c, Misses by 3c
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $79.34 +1.54%
Revenue Growth %: +11.2%
Financial Fact:
Interest expense, net: 81M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +11.2%
Financial Fact:
Interest expense, net: 81M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.90, ex-items, $0.03 worse than the analyst estimate of $0.93. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.29 billion.
Sales from the company's Cardiac and Vascular unit totaled $2.322 billion. Sales from the CRDM segment were $1.32 billion, down about 9 percent year-over-year.
Sales from the company's Cardiac and Vascular unit totaled $2.322 billion. Sales from the CRDM segment were $1.32 billion, down about 9 percent year-over-year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Reiterates Buy Rating on Medtronic, Inc. (MDT)
- Piper Sandler on Medtronic, Inc. (MDT): 'Warming to the Story but Not Quite There'
- John Wiley & Sons, Inc. (WLYB) Tops Q4 EPS by 12c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
